Morris County Chamber of Commerce
  • JOIN
    • Become a Member
    • Premier Membership
    • What Members Are Saying >
      • Share a Testimonial
    • Membership Inquiry
    • The Value of Membership >
      • Grow Your Business
      • Build Your Brand
      • Professional Development & Education
      • Government Advocacy
      • Community Outreach & Volunteering
    • New Member Survey
    • Power of Connection
  • About
    • Chamber Team
    • Our Mission
    • Our President
    • Board of Directors
    • Morris Business Cabinet
    • President's Circle
    • Chamber Champions
    • Ambassadors Council
    • Inclusivity Advisory Council
    • Frequently Asked Questions
    • Code of Conduct & COVID Policy
  • Membership
    • Member Benefits
    • Forums & Committees >
      • Business Development Forum
      • Business Strategy Forum
      • Health & Wellness Forum
      • Not For Profit Roundtable
      • Real Estate Forum
      • RISE Morris: Young Professionals Forum
      • Women in Business Program >
        • WIB Event Committee
    • Member to Member Deals
    • Member Marketing Opportunities
    • Grand Opening Support
    • Conference Room Usage
    • Member Referral Bonus
    • Connect to Morris Job Bank
  • Events
    • Chamber Event Calendar
    • Member Events Calendar
    • Signature Events & Programs
    • Golf Donations 2025
    • Event Photos
    • Submit an Event Idea
    • CCM Grant-Supported Training
  • Directory
    • Searchable Business Directory
    • Nonprofit Giving Guide 2024
    • Member Spotlights
    • Legal Resources >
      • Employment Law
      • Commercial Services
      • Business Representation
      • General Legal
    • Enhance Your Directory Listing
  • News & Info
    • Electronic Certificate of Origin
    • Business Resources & Info
    • Chamber Magazines
    • News Around the Chamber >
      • Around the Chamber Archive
      • Submit a Press Release
    • MCCC Blog >
      • Contribute to Our Blog
    • Members Library Submission
    • MCTV Let's Talk
    • Actionable Advice Video Library
  • Programs
    • Economic Development Corp
    • EDC Business Counseling
    • Public Policy Series
    • CEO Round Table
    • Lead Morris >
      • Lead Morris Program
      • Lead Morris Alumni Council
      • LEAD Morris Alumni Directory
      • Lead Morris FAQs
      • Lead Morris Application
      • LEAD Morris News & Info
      • Share a LEAD Morris Testimonial
    • Women In Business >
      • Women in Business Mastermind
      • Women in Business Executive Round Table
      • Women in Golf Program
    • Entrepreneur Roundtable
    • Thrive Morris >
      • Thrive Morris Community Leaders
      • Thrive Morris Blog
      • Contribute to the Thrive Morris Blog
  • Member Portal

Around the Chamber

​News & Information from our Members for our Members
​Click Here to submit your Press Release
​Click Here for Past 'Around the Chamber' eNewsletters

Pfizer Outlines Five-Point Plan to Battle COVID-19

3/19/2020

 
NEW YORK, March 13, 2020— Pfizer today issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19.
Dr. Albert Bourla, Chairman and CEO, made the following statement: “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including Pfizer, are working to develop antiviral therapies to help infected patients fight this emerging virus as well as new vaccines to prevent infection and halt the further spread of this disease. Pfizer is working to advance our own potential antiviral therapies and is engaged with BioNTech on a potential mRNA coronavirus vaccine. We are committed to work as one team across the industry to harness our scientific expertise, technical skills and manufacturing capabilities to combat this evolving crisis.”
Pfizer is making five promises that will help scientists more rapidly bring forward therapies and vaccines to protect humankind from this escalating pandemic and prepare the industry to better respond to future global health crises.
​
1. Sharing tools and insights: With very little known about this virus, many are working to develop cell-based assays, viral screening, serological assays, and translational models to test potential therapies and vaccines. Pfizer is committed to making the vital tools we develop available on an open source platform to the broader scientific community and to sharing the data and learnings gained with other companies in real time to rapidly advance therapies and vaccines to patients.

2. Marshalling our people: Human capital is our most valuable resource. Pfizer has created a SWAT team of our leading virologists, biologists, chemists, clinicians, epidemiologists, vaccine experts, pharmaceutical scientists and other key experts to focus solely on addressing this pandemic. This team is applying their passion, commitment and expertise to a single focus of accelerating the discovery and development process that will deliver therapies and vaccines to patients as soon as possible.

3. Applying our drug development expertise: Many smaller biotech companies are screening compounds or existing therapies for activity against the virus causing COVID-19, but some lack the experience in late stage development and navigating the complex regulatory systems. Pfizer is committed to sharing our clinical development and regulatory expertise to support the most promising candidates these companies bring forward.

4. Offering our manufacturing capabilities: Once a therapy or vaccine is approved it will need to be rapidly scaled and deployed around the world to put an end to this pandemic. As one of the largest manufacturers of vaccines and therapeutics, Pfizer is committed to using any excess manufacturing capacity and to potentially shifting production to support others in rapidly getting these life-saving breakthroughs into the hands of patients as quickly as possible.

5. Improving future rapid response: Finally, to address future global health threats, Pfizer is reaching out to federal agencies including NIH, NIAID and CDC to build a cross-industry rapid response team of scientists, clinicians and technicians able to move into action immediately when future epidemics surface.

“In recent years, the biopharmaceutical industry has brought forward some of the most impactful medical breakthroughs known to society, from therapies for HIV and cancer that have extended millions of lives to novel gene therapies that are seeing cure-like outcomes for some the most devastating rare diseases,” said Albert Bourla. “Pfizer calls on all members of the innovation ecosystem – from large pharmaceutical companies to the smallest of biotech companies, from government agencies to academic institutions – to commit to work together in addressing this dire crisis. With our combined efforts we know that there is no health challenge that we cannot overcome.”

###

Disclosure Notice: The information contained in this release is as of March 13, 2020. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.  This release contains forward-looking information about Pfizer’s efforts to battle COVID-19 that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including uncertainties regarding the results of screening and the ability to meet anticipated clinical endpoints, commencement and/or completion dates for our clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable pre-clinical or clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when drug applications for any potential antiviral compounds may be filed or approved in any jurisdictions, which will depend on myriad factors, including making a determination as to whether the product's benefits outweigh its known risks and determination of the product's efficacy; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of any such products; our manufacturing capabilities; and competitive developments. A further description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10- K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results", as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Comments are closed.

    Archives

    May 2025
    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020

    Categories

    All
    Bio Tech
    CARES Act
    Commercial Real Estate
    Coronavirus
    Economic Development
    Education
    Essential Business
    Event
    Giveaway
    Grants
    Healthcare
    Health & Wellness
    IT Solutions
    Loan Programs
    Mobile Service
    Morris County Chamber
    Neighbors Helping Neighbors
    News
    NJEDA
    Nonprofit
    Pharma
    Printers
    Pro Bono
    Retail
    Tourism
    Training
    Unemployment

    RSS Feed

Picture
JOIN Us   |   CONTACT Us  |  LEARN About Membership  |  REGISTER for Events  |  FIND a Member Business  |  READ our Magazines  |  LEAD Morris |  FAQ

Picture
325 Columbia Turnpike, ​​Suite 101
Florham Park, NJ 07932 

​973.539.3882 | CONTACT US | ​MAP
STAY CONNECTED: ​SIGN UP FOR UPDATES!
The Power of Connection!  Your membership connects you to valuable resources, opportunities for business growth and rewarding relationships with fellow members. And you don't need to be based in Morris County to belong!  
Our Business Hours are Monday to Friday, 9 am to 5 pm.  If you plan to stop by, it's best to make an appointment to ensure that someone will be available for you. Staff is often out of the office hosting events or meeting with members.
Follow  Us! 
The Morris County Economic Development Alliance (The Alliance) is an affiliated 501c3 Nonprofit of the Morris County Chamber and includes the Morris County Tourism Bureau, the Morris County Economic Development Corporation and the Connect To Morris job board.

©2025 Morris County Chamber of Commerce  |  A 501(c)(6) nonprofit membership organization  |  Site Map
  • JOIN
    • Become a Member
    • Premier Membership
    • What Members Are Saying >
      • Share a Testimonial
    • Membership Inquiry
    • The Value of Membership >
      • Grow Your Business
      • Build Your Brand
      • Professional Development & Education
      • Government Advocacy
      • Community Outreach & Volunteering
    • New Member Survey
    • Power of Connection
  • About
    • Chamber Team
    • Our Mission
    • Our President
    • Board of Directors
    • Morris Business Cabinet
    • President's Circle
    • Chamber Champions
    • Ambassadors Council
    • Inclusivity Advisory Council
    • Frequently Asked Questions
    • Code of Conduct & COVID Policy
  • Membership
    • Member Benefits
    • Forums & Committees >
      • Business Development Forum
      • Business Strategy Forum
      • Health & Wellness Forum
      • Not For Profit Roundtable
      • Real Estate Forum
      • RISE Morris: Young Professionals Forum
      • Women in Business Program >
        • WIB Event Committee
    • Member to Member Deals
    • Member Marketing Opportunities
    • Grand Opening Support
    • Conference Room Usage
    • Member Referral Bonus
    • Connect to Morris Job Bank
  • Events
    • Chamber Event Calendar
    • Member Events Calendar
    • Signature Events & Programs
    • Golf Donations 2025
    • Event Photos
    • Submit an Event Idea
    • CCM Grant-Supported Training
  • Directory
    • Searchable Business Directory
    • Nonprofit Giving Guide 2024
    • Member Spotlights
    • Legal Resources >
      • Employment Law
      • Commercial Services
      • Business Representation
      • General Legal
    • Enhance Your Directory Listing
  • News & Info
    • Electronic Certificate of Origin
    • Business Resources & Info
    • Chamber Magazines
    • News Around the Chamber >
      • Around the Chamber Archive
      • Submit a Press Release
    • MCCC Blog >
      • Contribute to Our Blog
    • Members Library Submission
    • MCTV Let's Talk
    • Actionable Advice Video Library
  • Programs
    • Economic Development Corp
    • EDC Business Counseling
    • Public Policy Series
    • CEO Round Table
    • Lead Morris >
      • Lead Morris Program
      • Lead Morris Alumni Council
      • LEAD Morris Alumni Directory
      • Lead Morris FAQs
      • Lead Morris Application
      • LEAD Morris News & Info
      • Share a LEAD Morris Testimonial
    • Women In Business >
      • Women in Business Mastermind
      • Women in Business Executive Round Table
      • Women in Golf Program
    • Entrepreneur Roundtable
    • Thrive Morris >
      • Thrive Morris Community Leaders
      • Thrive Morris Blog
      • Contribute to the Thrive Morris Blog
  • Member Portal